Discover the detailed record of transactions filed by HARGREAVES BRADLEY S, Former Vice President, Technology and Operations; Director. Insider active across 1 companies, notably Cell MedX Corp.. Aggregated, 39 reports have been recorded. Total volume traded: €216k. The latest transaction was filed on 6 April 2022 — Cession. Regulator: SEC (Form 4). All data is openly available.
25 of 39 declarations
Bradley S. Hargreaves is an executive associated with Cell MedX Corp., where he served as Vice President, Technology and Operations, and as a director. Publicly available sources present him primarily as a technical and operations-focused leader rather than a broad-based corporate generalist. His background is in engineering and hands-on operations, including two journeyman-level operations credentials and a four-year operations certification from Shell Canada. That training appears to have shaped his role at Cell MedX, where he was positioned to support research and development and to oversee the ongoing development of the company’s technology from an engineering standpoint. ([people.equilar.com](https://people.equilar.com/bio/person/bradley-hargreaves-cell-medx-corp/13683775?utm_source=openai)) Prior to, and alongside, his work with Cell MedX, Hargreaves served as director of operations and principal of XC Velle Institute Inc., a privately held technology and spa company, beginning in 2009. Public records also indicate that from roughly 2002 to 2009 he worked in operations for a privately held spa business with up to 15 employees. Taken together, these roles suggest a career built around operational execution, process improvement, and applied technical support in service-oriented and technology-adjacent businesses. ([people.equilar.com](https://people.equilar.com/bio/person/bradley-hargreaves-cell-medx-corp/13683775?utm_source=openai)) At Cell MedX, his responsibilities appear to have included researching the company’s e-balance technology, designing and improving treatment protocols, and providing technical support to the R&D team. The available records do not clearly document high-profile standalone strategic decisions or large-scale corporate turnarounds led by him; therefore, it is more accurate to describe his contribution in terms of technical stewardship, operational continuity, and product-development support. Overall, Bradley S. Hargreaves comes across as an engineering-minded operator whose value proposition is rooted in technical implementation, disciplined operations, and sustained support for early-stage or specialized corporate initiatives. ([people.equilar.com](https://people.equilar.com/bio/person/bradley-hargreaves-cell-medx-corp/13683775?utm_source=openai))